Related Experiment Video
Updated: Jan 26, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Identification of prognostic factors in patients with diffuse large B-cell lymphoma
Fang Peng1, Liang Guo1, Wei-Kai Yao1
1Department of Pathology, The First Hospital of Jilin University, Changchun, China.
Insights
Prognostic factors like ECOG performance score and specific protein expressions (Bcl-2, CD10, Bcl-6) predict outcomes in diffuse large B-cell lymphoma (DLBCL). These factors remain significant even in cases with conflicting classifications.
Area of Science:
- Hematology
- Oncology
- Immunohistochemistry
Background:
- Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease.
- Prognostic classification algorithms like Hans' and Choi's aid in predicting patient outcomes.
- Conflicting classifications between algorithms can complicate prognostic assessment.
Purpose of the Study:
- To identify prognostic factors for de novo diffuse large B-cell lymphoma (DLBCL) patients.
- To evaluate prognostic factors in DLBCL cases with conflicting classifications by Hans' and Choi's algorithms.
- To assess the concordance and clinical relevance of two major DLBCL classification algorithms.
Main Methods:
- Retrospective review of clinical and pathological data from 154 de novo DLBCL patients.
- Classification of DLBCL subtypes using Hans' and Choi's algorithms with immunohistochemical markers.
- Statistical analysis of clinicopathological factors, International Prognostic Index, and 5-year survival rates.
Main Results:
- Eastern Cooperative Oncology Group (ECOG) performance score 2-5, positive Bcl-2, negative CD10, and negative Bcl-6 expression correlated with worse prognosis.
- Hans' and Choi's algorithms showed good concordance (83% agreement, Kappa = 0.660).
- Germinal center B-cell-like (GCB) subtype had significantly better 5-year overall survival than non-GCB subtypes by both classifications.
- In the 25 cases with conflicting classifications, the same adverse prognostic factors (ECOG 2-5, positive Bcl-2, negative CD10, negative Bcl-6) were identified.
Conclusions:
- ECOG performance score 2-5, positive Bcl-2, negative CD10, and negative Bcl-6 expression are independent markers for poor prognosis in DLBCL.
- These prognostic markers retain significance even in DLBCL cases with conflicting classifications between Hans' and Choi's algorithms.
- The study highlights key immunohistochemical markers for predicting DLBCL patient outcomes, irrespective of classification algorithm discrepancies.
Abstract:
To identify prognostic factors for patients with diffuse large B-cell lymphoma (DLBCL), specifically those classified into conflicting subgroups by Hans' and Choi's classification algorithms. We retrospectively reviewed clinical and pathological data of 154 patients diagnosed with de novo DLBCL in the First Hospital of Jilin University from January 2004 to September 2011. All cases were classified into subgroups based on Hans' and Choi's algorithms with immunohistochemical markers.
Statistical Analysis Used:
The correlation between various clinicopathological factors and 5-year survival rate, the correlation between those factors with the International Prognostic Index, the concordance between Hans' and Choi's approach was evaluated. The survival in different subtypes as classified by Hans' or Choi's approach was mapped.
Results:
The Eastern Cooperative Oncology Group (ECOG) performance score 2-5, positive Bcl-2 expression, negative CD10 expression or negative Bcl-6 expression significantly correlated with worse prognosis. The two algorithms showed good consistency (83% concordance, Kappa = 0.660, P < 0.001). By both classifications, the 5-year overall survival rate in germinal center B-cell-like subtype (GCB) lymphoma is significantly higher than that in the non-GCB subtype. There were 25 cases assigned to conflicting subtypes by the two approaches. Among these 25 cases, ECOG 2-5, positive Bcl-2 expression, negative CD10 expression, or negative Bcl-6 expression significantly correlated with worse prognosis.
Conclusions:
ECOG 2-5, positive Bcl-2 expression, negative CD10 expression, or negative Bcl-6 expression are independent markers for poor prognosis of DLBCL patients. There were 15% cases assigned to conflicting subgroups based on the two algorithms. For these cases, ECOG 2-5, positive Bcl-2 expression, negative CD10 expression, or negative Bcl-6 expression still significantly correlate with poor prognosis.
Related Concept Videos
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Diffusion
Diffusion
Transcription Factors
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Facilitated Diffusion
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...

